Global and China Follicular Lymphoma Treatment Market Size, Status and Forecast 2020-2026

Global and China Follicular Lymphoma Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Monoclonal Antibodies
1.2.5 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Follicular Lymphoma Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Treatment Market Perspective (2015-2026)
2.2 Global Follicular Lymphoma Treatment Growth Trends by Regions
2.2.1 Follicular Lymphoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Follicular Lymphoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Follicular Lymphoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Treatment Players by Market Size
3.1.1 Global Top Follicular Lymphoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Follicular Lymphoma Treatment Revenue
3.4 Global Follicular Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Treatment Revenue in 2019
3.5 Key Players Follicular Lymphoma Treatment Area Served
3.6 Key Players Follicular Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Follicular Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Treatment Breakdown Data by Type (2015-2026)
4.1 Global Follicular Lymphoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2021-2026)
5 Follicular Lymphoma Treatment Breakdown Data by Application (2015-2026)
5.1 Global Follicular Lymphoma Treatment Historic Market Size by Application (2015-2020)
5.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Follicular Lymphoma Treatment Market Size (2015-2026)
6.2 North America Follicular Lymphoma Treatment Market Size by Type (2015-2020)
6.3 North America Follicular Lymphoma Treatment Market Size by Application (2015-2020)
6.4 North America Follicular Lymphoma Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Follicular Lymphoma Treatment Market Size (2015-2026)
7.2 Europe Follicular Lymphoma Treatment Market Size by Type (2015-2020)
7.3 Europe Follicular Lymphoma Treatment Market Size by Application (2015-2020)
7.4 Europe Follicular Lymphoma Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Follicular Lymphoma Treatment Market Size (2015-2026)
8.2 China Follicular Lymphoma Treatment Market Size by Type (2015-2020)
8.3 China Follicular Lymphoma Treatment Market Size by Application (2015-2020)
8.4 China Follicular Lymphoma Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Follicular Lymphoma Treatment Market Size (2015-2026)
9.2 Japan Follicular Lymphoma Treatment Market Size by Type (2015-2020)
9.3 Japan Follicular Lymphoma Treatment Market Size by Application (2015-2020)
9.4 Japan Follicular Lymphoma Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Follicular Lymphoma Treatment Market Size (2015-2026)
10.2 Southeast Asia Follicular Lymphoma Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Follicular Lymphoma Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Follicular Lymphoma Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Details
11.1.2 Boehringer Ingelheim GmbH Business Overview
11.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
11.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2015-2020))
11.1.5 Boehringer Ingelheim GmbH Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
11.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.3.5 Celgene Corporation Recent Development
11.4 Celldex Therapeutics, Inc.
11.4.1 Celldex Therapeutics, Inc. Company Details
11.4.2 Celldex Therapeutics, Inc. Business Overview
11.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
11.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.4.5 Celldex Therapeutics, Inc. Recent Development
11.5 Celltrion, Inc.
11.5.1 Celltrion, Inc. Company Details
11.5.2 Celltrion, Inc. Business Overview
11.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
11.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.5.5 Celltrion, Inc. Recent Development
11.6 Cellular Biomedicine Group, Inc.
11.6.1 Cellular Biomedicine Group, Inc. Company Details
11.6.2 Cellular Biomedicine Group, Inc. Business Overview
11.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
11.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.6.5 Cellular Biomedicine Group, Inc. Recent Development
11.7 Coherus BioSciences, Inc.
11.7.1 Coherus BioSciences, Inc. Company Details
11.7.2 Coherus BioSciences, Inc. Business Overview
11.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
11.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.7.5 Coherus BioSciences, Inc. Recent Development
11.8 CTI BioPharma Corp.
11.8.1 CTI BioPharma Corp. Company Details
11.8.2 CTI BioPharma Corp. Business Overview
11.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
11.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.8.5 CTI BioPharma Corp. Recent Development
11.9 Curis, Inc.
11.9.1 Curis, Inc. Company Details
11.9.2 Curis, Inc. Business Overview
11.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
11.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.9.5 Curis, Inc. Recent Development
11.10 Dynavax Technologies Corporation
11.10.1 Dynavax Technologies Corporation Company Details
11.10.2 Dynavax Technologies Corporation Business Overview
11.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
11.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020)
11.10.5 Dynavax Technologies Corporation Recent Development
11.11 Eisai
10.11.1 Eisai Company Details
10.11.2 Eisai Business Overview
10.11.3 Eisai Follicular Lymphoma Treatment Introduction
10.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.11.5 Eisai Recent Development
11.12 EpiZyme, Inc.
10.12.1 EpiZyme, Inc. Company Details
10.12.2 EpiZyme, Inc. Business Overview
10.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
10.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.12.5 EpiZyme, Inc. Recent Development
11.13 F. Hoffmann-La Roche Ltd.
10.13.1 F. Hoffmann-La Roche Ltd. Company Details
10.13.2 F. Hoffmann-La Roche Ltd. Business Overview
10.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
10.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.13.5 F. Hoffmann-La Roche Ltd. Recent Development
11.14 Genentech, Inc.
10.14.1 Genentech, Inc. Company Details
10.14.2 Genentech, Inc. Business Overview
10.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
10.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.14.5 Genentech, Inc. Recent Development
11.15 Gilead Sciences, Inc.
10.15.1 Gilead Sciences, Inc. Company Details
10.15.2 Gilead Sciences, Inc. Business Overview
10.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
10.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.15.5 Gilead Sciences, Inc. Recent Development
11.16 GlaxoSmithKline Plc
10.16.1 GlaxoSmithKline Plc Company Details
10.16.2 GlaxoSmithKline Plc Business Overview
10.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
10.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.16.5 GlaxoSmithKline Plc Recent Development
11.17 Hutchison MediPharma Limited
10.17.1 Hutchison MediPharma Limited Company Details
10.17.2 Hutchison MediPharma Limited Business Overview
10.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
10.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.17.5 Hutchison MediPharma Limited Recent Development
11.18 Immune Design Corp.
10.18.1 Immune Design Corp. Company Details
10.18.2 Immune Design Corp. Business Overview
10.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
10.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.18.5 Immune Design Corp. Recent Development
11.19 ImmunoGen, Inc.
10.19.1 ImmunoGen, Inc. Company Details
10.19.2 ImmunoGen, Inc. Business Overview
10.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
10.19.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
10.19.5 ImmunoGen, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Follicular Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Stem Cell Transplantation
Table 7. Global Follicular Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Follicular Lymphoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Follicular Lymphoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Follicular Lymphoma Treatment Market Share by Regions (2015-2020)
Table 11. Global Follicular Lymphoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Follicular Lymphoma Treatment Market Share by Regions (2021-2026)
Table 13. Follicular Lymphoma Treatment Market Market Trends
Table 14. Follicular Lymphoma Treatment Market Drivers
Table 15. Follicular Lymphoma Treatment Market Challenges
Table 16. Follicular Lymphoma Treatment Market Restraints
Table 17. Global Follicular Lymphoma Treatment Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Follicular Lymphoma Treatment Market Share by Players (2015-2020)
Table 19. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2019)
Table 20. Global Follicular Lymphoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Follicular Lymphoma Treatment Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Follicular Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Follicular Lymphoma Treatment Market Size Share by Type (2015-2020)
Table 26. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2021-2026)
Table 27. Global Follicular Lymphoma Treatment Market Size Share by Application (2015-2020)
Table 28. Global Follicular Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Follicular Lymphoma Treatment Market Size Share by Application (2021-2026)
Table 30. North America Follicular Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 32. North America Follicular Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 34. North America Follicular Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Follicular Lymphoma Treatment Market Share by Country (2015-2020)
Table 36. Europe Follicular Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 38. Europe Follicular Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 40. Europe Follicular Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Follicular Lymphoma Treatment Market Share by Country (2015-2020)
Table 42. China Follicular Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 43. China Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 44. China Follicular Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 45. China Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 46. China Follicular Lymphoma Treatment Market Size by Region (US$ Million) (2015-2020)
Table 47. China Follicular Lymphoma Treatment Market Share by Region (2015-2020)
Table 48. Japan Follicular Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 50. Japan Follicular Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 52. Japan Follicular Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Follicular Lymphoma Treatment Market Share by Country (2015-2020)
Table 54. Southeast Asia Follicular Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 56. Southeast Asia Follicular Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Follicular Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Follicular Lymphoma Treatment Market Share by Country (2015-2020)
Table 60. Boehringer Ingelheim GmbH Company Details
Table 61. Boehringer Ingelheim GmbH Business Overview
Table 62. Boehringer Ingelheim GmbH Product
Table 63. Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 64. Boehringer Ingelheim GmbH Recent Development
Table 65. Bristol-Myers Squibb Company Company Details
Table 66. Bristol-Myers Squibb Company Business Overview
Table 67. Bristol-Myers Squibb Company Product
Table 68. Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 69. Bristol-Myers Squibb Company Recent Development
Table 70. Celgene Corporation Company Details
Table 71. Celgene Corporation Business Overview
Table 72. Celgene Corporation Product
Table 73. Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 74. Celgene Corporation Recent Development
Table 75. Celldex Therapeutics, Inc. Company Details
Table 76. Celldex Therapeutics, Inc. Business Overview
Table 77. Celldex Therapeutics, Inc. Product
Table 78. Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 79. Celldex Therapeutics, Inc. Recent Development
Table 80. Celltrion, Inc. Company Details
Table 81. Celltrion, Inc. Business Overview
Table 82. Celltrion, Inc. Product
Table 83. Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 84. Celltrion, Inc. Recent Development
Table 85. Cellular Biomedicine Group, Inc. Company Details
Table 86. Cellular Biomedicine Group, Inc. Business Overview
Table 87. Cellular Biomedicine Group, Inc. Product
Table 88. Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 89. Cellular Biomedicine Group, Inc. Recent Development
Table 90. Coherus BioSciences, Inc. Company Details
Table 91. Coherus BioSciences, Inc. Business Overview
Table 92. Coherus BioSciences, Inc. Product
Table 93. Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 94. Coherus BioSciences, Inc. Recent Development
Table 95. CTI BioPharma Corp. Business Overview
Table 96. CTI BioPharma Corp. Product
Table 97. CTI BioPharma Corp. Company Details
Table 98. CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 99. CTI BioPharma Corp. Recent Development
Table 100. Curis, Inc. Company Details
Table 101. Curis, Inc. Business Overview
Table 102. Curis, Inc. Product
Table 103. Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 104. Curis, Inc. Recent Development
Table 105. Dynavax Technologies Corporation Company Details
Table 106. Dynavax Technologies Corporation Business Overview
Table 107. Dynavax Technologies Corporation Product
Table 108. Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 109. Dynavax Technologies Corporation Recent Development
Table 110. Eisai Company Details
Table 111. Eisai Business Overview
Table 112. Eisai Product
Table 113. Eisai Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 114. Eisai Recent Development
Table 115. EpiZyme, Inc. Company Details
Table 116. EpiZyme, Inc. Business Overview
Table 117. EpiZyme, Inc. Product
Table 118. EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 119. EpiZyme, Inc. Recent Development
Table 120. F. Hoffmann-La Roche Ltd. Company Details
Table 121. F. Hoffmann-La Roche Ltd. Business Overview
Table 122. F. Hoffmann-La Roche Ltd. Product
Table 123. F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 124. F. Hoffmann-La Roche Ltd. Recent Development
Table 125. Genentech, Inc. Company Details
Table 126. Genentech, Inc. Business Overview
Table 127. Genentech, Inc. Product
Table 128. Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 129. Genentech, Inc. Recent Development
Table 130. Gilead Sciences, Inc. Company Details
Table 131. Gilead Sciences, Inc. Business Overview
Table 132. Gilead Sciences, Inc. Product
Table 133. Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 134. Gilead Sciences, Inc. Recent Development
Table 135. GlaxoSmithKline Plc Company Details
Table 136. GlaxoSmithKline Plc Business Overview
Table 137. GlaxoSmithKline Plc Product
Table 138. GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 139. GlaxoSmithKline Plc Recent Development
Table 140. Hutchison MediPharma Limited Company Details
Table 141. Hutchison MediPharma Limited Business Overview
Table 142. Hutchison MediPharma Limited Product
Table 143. Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 144. Hutchison MediPharma Limited Recent Development
Table 145. Immune Design Corp. Company Details
Table 146. Immune Design Corp. Business Overview
Table 147. Immune Design Corp. Product
Table 148. Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 149. Immune Design Corp. Recent Development
Table 150. ImmunoGen, Inc. Company Details
Table 151. ImmunoGen, Inc. Business Overview
Table 152. ImmunoGen, Inc. Product
Table 153. ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 154. ImmunoGen, Inc. Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Follicular Lymphoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Stem Cell Transplantation Features
Figure 6. Global Follicular Lymphoma Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Follicular Lymphoma Treatment Report Years Considered
Figure 11. Global Follicular Lymphoma Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Follicular Lymphoma Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Follicular Lymphoma Treatment Market Share by Regions (2021-2026)
Figure 14. Global Follicular Lymphoma Treatment Market Share by Players in 2019
Figure 15. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Follicular Lymphoma Treatment Revenue in 2019
Figure 17. North America Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Follicular Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Boehringer Ingelheim GmbH Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 45. Bristol-Myers Squibb Company Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 46. Celgene Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 47. Celldex Therapeutics, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 48. Celltrion, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 49. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 50. Coherus BioSciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 51. CTI BioPharma Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 52. Curis, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 53. Dynavax Technologies Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 54. Eisai Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 55. EpiZyme, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 56. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 57. Genentech, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 58. Gilead Sciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 60. Hutchison MediPharma Limited Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 61. Immune Design Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 62. ImmunoGen, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs